# Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye

> **NCT01657253** · PHASE3 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 183 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** PRO-148
- **DRUG:** Systane

## Key facts

- **NCT ID:** NCT01657253
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-04
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2017-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657253, "Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01657253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*